IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: I. Luttichuys who wrote (295)	1/21/1997 8:47:00 PM
From: Brad C. Dunlap	of 1762

Hi bennett and all, just a few thoughts. I strongly believe the weakness is partially due to Coulter's presentations that have been going on and should continue until approx Jan 27,28 when they should be priced on their public offering. It is only common sence to think that in all the presentations that H&Q and Alex Brown have them doing that they are making unfriendly comments about Idec.They have done it before so I suspect that they're doing it again. This will come to an end and I suspect the stock will perform better when the time comes. Secondly, Eric Hecht has left Morgan Stanley to work for Merrill Lynch. My understanding is that Eric is currently on vacation and now Idec is an easy stock to sell at Morgan since there is no active coverage. This should work out to be a long term positive once Eric gets situated at Merrill and picks up coverage due to the much greater exposure that Merrill has compared to Morgan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next